Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatment of Parkinson's disease. The company also develops DNL310 that is in Phase I/II clinical trials for the treatment of hunter syndrome; DNL343, which is in phase 1 clinical trial the treatment of amyotrophic lateral sclerosis (ALS); AR443820/DNL788 completed a phase I clinical trial for the treatment of ALS, multiple sclerosis (MS), and Alzheimer's disease; and SAR443122/DNL758, which is in phase II clinical trial for the treatment of cutaneous lupus erythematosus. It has collaboration agreement with Takeda Pharmaceutical Company, Genentech, Inc., Sanofi, F-star Gamma Limited, F-star Biotechnologische Forschungs-Und Entwicklungsges M.B.H, F-star Biotechnology Limited, SIRION Biotech GmbH, Genzyme Corporation, Harvard University, the Michael J. Fox Foundation, and Centogene; and a research and option agreement with Secarna Pharmaceuticals GmbH & Co. KG. to develop antisense therapies in the field of neurodegenerative diseases. The company was formerly known as SPR Pharma Inc. and changed its name to Denali Therapeutics Inc. in March 2015. Denali Therapeutics Inc. was incorporated in 2013 and is headquartered in South San Francisco, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Denali Therapeutics Inc..
Denali Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Denali Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Denali Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Denali Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Denali Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Denali Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Denali Therapeutics Inc.- Key Facts
2.2 Denali Therapeutics Inc.- Geographic Locations
2.3 Denali Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Denali Therapeutics Inc.- Business Divisions
2.5 Denali Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Denali Therapeutics Inc. Strategic Analysis Review
3.1 Denali Therapeutics Inc.- Key Strategies
3.2 Denali Therapeutics Inc.- Company Outlook Statement
3.3 Denali Therapeutics Inc.- SWOT Analysis
3.3.1 Denali Therapeutics Inc.- Key Strengths
3.3.2 Denali Therapeutics Inc.- Key Weaknesses
3.3.3 Denali Therapeutics Inc.- Potential Opportunities
3.3.4 Denali Therapeutics Inc.- Potential Threats
3.4 Denali Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Denali Therapeutics Inc.- Business Overview
4.2 Denali Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Denali Therapeutics Inc.- Key Products
5.2 Denali Therapeutics Inc.- Key Service Areas
5.3 Denali Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Denali Therapeutics Inc.- Company History
6.2 Denali Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Denali Therapeutics Inc.- Income Statements
7.2 Denali Therapeutics Inc.- Balance Sheet
7.3 Denali Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Denali Therapeutics Inc.- Direct Competitors
8.2 Denali Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Denali Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Denali Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
